AI scribes are already one of the most beneficial digital tools available to relieve clinical burden, improve documentation quality, and free up time for patient care. But with excitement comes the need for critical evaluation: understanding not just what they can do, but what they cost, where they fit, and how they align with broader digital strategy. Join Richard Nankervis as he shares results from Hunter New England and Central Coast PHN’s evaluation of the real-world impact of AI scribes in primary care, unpacking benefits, risks, and policy considerations while discussing how localised, micro-level efficiencies can translate into system-wide transformation.
- Assessing the true cost–benefit equation of AI scribes across clinical settings
- Integrating AI tools safely and ethically within digital and data governance frameworks